ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB082

Prevalence of Testing for Albuminuria in Saudi Adults at Risk for CKD

Session Information

Category: Diabetic Kidney Disease

  • 702 Diabetic Kidney Disease: Clinical

Author

  • Albekery, Mohamed, King Faisal University, Al Ahsa, Eastern Province, Saudi Arabia
Background

DM and HTN are the most significant risk factors leading to CKD. Early detection through urine albumin-to-creatinine ratio is important to improve outcomes and reducing the progression of CKD. The aim of our study is to estimate the prevalence of albuminuria testing in primary health care clinics among Saudi patients at risk of developing CKD

Methods

This single-center, cross-sectional, we included adults aged 18 years or older who were diagnosed with DM and/or HTN and had attended at least two outpatient visits within the study year.

Results

A total of 516 eligible patients were included in this study. 16.1% had HTN alone, 11.4% had DM alone, and 72.5% had both HTN and DM. The prevalence of ACR testing was 69% in patients with DM alone, while it was 66% in those with both HTN and DM. Only 19% of those with HTN alone had at least one ACR testing. Patients who underwent ACR testing had significantly higher HbA1c levels (mean = 7.5) compared to those who did not (mean = 6.6; p < 0.001). They also had a higher number of outpatient visits.

Conclusion

Despite clinical recommendations, ACR testing remains suboptimal, particularly among patients with HTN and DM. These findings highlight gaps in adherence to KDIGO guidelines in primary care, especially among HTN and DM patients

Digital Object Identifier (DOI)